Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Croagh, Daniel [VerfasserIn]   i
 Michalski, Christoph [VerfasserIn]   i
 van Berge Henegouwen, Mark I. [VerfasserIn]   i
 Alfieri, Sergio [VerfasserIn]   i
Titel:Diagnosis and management of pancreatic insufficiency in patients with gastrectomy due to cancer or gastric ulcers
Titelzusatz:a virtual roundtable expert discussion
Verf.angabe:Daniel Croagh, Christoph W. Michalski, Mark I. van Berge Henegouwen & Sergio Alfieri
E-Jahr:2023
Jahr:27 Dec 2023
Umfang:7 S.
Fussnoten:Gesehen am 15.03.2024
Titel Quelle:Enthalten in: Expert review of gastroenterology & hepatology
Ort Quelle:Abingdon, Oxon : Taylor & Francis, 2007
Jahr Quelle:2023
Band/Heft Quelle:17(2023), 12, Seite 1313-1319
ISSN Quelle:1747-4132
Abstract:Pancreatic exocrine insufficiency (PEI) is common after gastric resection for cancer or ulcers but is under-recognized and undertreated. Although pancreatic enzyme replacement therapy (PERT) is the mainstay of PEI management, robust evidence supporting its use after gastric surgery is limited. In the absence of guideline recommendations specific for patients with pancreatic insufficiency after gastrectomy, a panel of experts from different geographical regions convened in a virtual meeting to discuss their approach to patient management. Pancreatic insufficiency after gastrointestinal surgery is not a simple post-surgical complication as several factors contribute to its development. Although the pancreas is unimpaired after gastrectomy, it cannot function normally in the altered environment. Pancreatic insufficiency can be challenging to diagnose in gastrectomy patients due to nonspecific symptoms and the absence of a simple diagnostic test. Fecal elastase appears to be the default test, although it is not sufficiently sensitive nor reliable for diagnosing or monitoring PEI. Patients with maldigestion symptoms after gastrectomy are treated pragmatically: those with clinical suspicion of pancreatic insufficiency receive a trial of PERT and are monitored for symptom improvement. There is a clear need for high-quality evidence from clinical trials to guide the management of this patient population.
DOI:doi:10.1080/17474124.2023.2296762
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1080/17474124.2023.2296762
 DOI: https://doi.org/10.1080/17474124.2023.2296762
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:expert opinion
 gastrectomy
 maldigestion syndrome
 pancreatic enzyme replacement therapy
 Pancreatic exocrine insufficiency
K10plus-PPN:1883569362
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69192379   QR-Code

zum Seitenanfang